Rhenman & Partners Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-48,000
| Closed | -$1.32M | – | 94 |
|
|
2024
Q1 | $1.32M | Sell |
48,000
-2,000
| -4% | -$55K | 0.13% | 80 |
|
|
2023
Q4 | $1.52M | Hold |
50,000
| – | – | 0.15% | 77 |
|
|
2023
Q3 | $1.58M | Hold |
50,000
| – | – | 0.17% | 77 |
|
|
2023
Q2 | $2.04M | Hold |
50,000
| – | – | 0.21% | 74 |
|
|
2023
Q1 | $1.8M | Hold |
50,000
| – | – | 0.2% | 77 |
|
|
2022
Q4 | $1.74M | Hold |
50,000
| – | – | 0.18% | 86 |
|
|
2022
Q3 | $2.64M | Hold |
50,000
| – | – | 0.28% | 78 |
|
|
2022
Q2 | $2.59M | Hold |
50,000
| – | – | 0.29% | 73 |
|
|
2022
Q1 | $3.63M | Buy |
+50,000
| New | +$3.63M | 0.36% | 72 |
|